APOE ε4 and Intracerebral Hemorrhage in Patients With Brain Arteriovenous Malformation

被引:1
|
作者
Renedo, Daniela [1 ,2 ]
Rivier, Cyprien A. [1 ]
Koo, Andrew B. [2 ]
Sujijantarat, Nanthiya [2 ]
Clocchiatti-Tuozzo, Santiago [1 ,3 ]
Wu, Kane [1 ]
Torres-Lopez, Victor M. [1 ]
Huo, Shufan [1 ]
Gunel, Murat [2 ]
de Havenon, Adam [1 ,3 ]
Sheth, Kevin N. [1 ,2 ,3 ]
Matouk, Charles C. [2 ]
Falcone, Guido J. [1 ,3 ]
机构
[1] Yale Sch Med, Dept Neurol, 15 York St,LLCI Room 1004D,POB 208018, New Haven, CT 06510 USA
[2] Yale Sch Med, Dept Neurosurg, New Haven, CT USA
[3] Yale Ctr Brain & Mind Hlth, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
D O I
10.1001/jamanetworkopen.2023.55368
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Intracerebral hemorrhage (ICH) is a serious complication of brain arteriovenous malformation (AVM). Apolipoprotein E (APOE) epsilon 4 is a well-known genetic risk factor for ICH among persons without AVM, and cerebral amyloid angiopathy is a vasculopathy frequently observed in APOE epsilon 4 carriers that may increase the risk of ICH. Objective To assess whether APOE epsilon 4 is associated with a higher risk of ICH in patients with a known AVM. Design, Setting, and Participants This cross-sectional study including 412 participants was conducted in 2 stages (discovery and replication) using individual-level data from the UK Biobank (released March 2012 and last updated October 2023) and the All of Us Research Program (commenced on May 6, 2018, with its latest update provided in October 2023). The occurrence of AVM and ICH was ascertained at the time of enrollment using validated International Classification of Diseases, Ninth Revision and Tenth Revision, codes. Genotypic data on the APOE variants rs429358 and rs7412 were used to ascertain the epsilon status. Main Outcomes and Measures For each study, the association between APOE epsilon 4 variants and ICH risk was assessed among patients with a known AVM by using multivariable logistic regression. Results The discovery phase included 253 UK Biobank participants with known AVM (mean [SD] age, 56.6 [8.0] years, 119 [47.0%] female), of whom 63 (24.9%) sustained an ICH. In the multivariable analysis of 240 participants of European ancestry, APOE epsilon 4 was associated with a higher risk of ICH (odds ratio, 4.58; 95% CI, 2.13-10.34; P < .001). The replication phase included 159 participants with known AVM enrolled in All of Us (mean [SD] age, 57.1 [15.9] years; 106 [66.7%] female), of whom 29 (18.2%) sustained an ICH. In multivariable analysis of 101 participants of European ancestry, APOE epsilon 4 was associated with higher risk of ICH (odds ratio, 4.52; 95% CI, 1.18-19.38; P = .03). Conclusions and Relevance The results of this cross-sectional study of patients from the UK Biobank and All of Us suggest that information on APOE epsilon 4 status may help identify patients with brain AVM who are at particularly high risk of ICH and that cerebral amyloid angiopathy should be evaluated as a possible mediating mechanism of the observed association.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Association of APOE ε4 with progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage
    Wan, Xueyan
    Gan, Chao
    You, Chao
    Fan, Ting
    Zhang, Suojun
    Zhang, Huaqiu
    Wang, Sheng
    Shu, Kai
    Wang, Xiong
    Lei, Ting
    JOURNAL OF NEUROSURGERY, 2020, 133 (02) : 496 - 503
  • [22] A case of cerebral arteriovenous malformation complicated with intracerebral hemorrhage after endovascular embolization
    Hayashi, K
    Takahata, H
    Kitagawa, N
    Morikawa, M
    Ochi, M
    Hayashi, T
    Kazekawa, K
    Kaminogo, M
    Shibata, S
    NEUROLOGICAL SURGERY, 2001, 29 (04): : 353 - 358
  • [23] SCANNING WITH POSITRON-EMITTING RADIOISOTOPES - ANEURYSM ARTERIOVENOUS MALFORMATION AND INTRACEREBRAL HEMORRHAGE
    OJEMANN, RG
    ARONOW, S
    SWEET, WH
    JOURNAL OF NEUROSURGERY, 1965, 22 (05) : 489 - &
  • [24] Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients
    Kim, Helen
    Sidney, Stephen
    Johnston, S. Claiborne
    Ko, Nerissa U.
    Singh, Vineeta
    Achrol, Achal S.
    Poon, K. Y. Trudy
    McCulloch, Charles E.
    Young, William L.
    STROKE, 2007, 38 (02) : 468 - 468
  • [25] Clinical outcome after first and subsequent hemorrhage in patients with untreated brain arteriovenous malformation
    Choi, JH
    Mohr, JP
    Sciacca, RR
    Hartmann, A
    Khaw, AV
    Mast, H
    Sacco, RL
    Stapf, C
    STROKE, 2005, 36 (02) : 464 - 464
  • [26] Racial/Ethnic differences in longitudinal risk of intracranial Hemorrhage in brain arteriovenous malformation patients
    Kim, Helen
    Sidney, Stephen
    McCulloch, Charles E.
    Poon, K. Y. Trudy
    Singh, Vineeta
    Johnston, S. Claiborne
    Ko, Nerissa U.
    Achrol, Achal S.
    Lawton, Michael T.
    Higashida, Randall T.
    Young, William L.
    STROKE, 2007, 38 (09) : 2430 - 2437
  • [27] Susceptible gene single nucleotide polymorphism and hemorrhage risk in patients with brain arteriovenous malformation
    Jiang, Nan
    Li, Xuesong
    Qi, Tiewei
    Guo, Shaolei
    Liang, Feng
    Huang, Zhengsong
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (09) : 1279 - 1281
  • [28] The effect of smoking and arterial hypertension on intracranial hemorrhage in patients with brain arteriovenous malformation.
    Labovitz, DL
    Convery, AB
    Khaw, AV
    Sciacca, RR
    Mast, H
    Mohr, JP
    Stapf, C
    STROKE, 2004, 35 (01) : 329 - 329
  • [29] Long-term Treatment Risk Of Hemorrhage In Unruptured Brain Arteriovenous Malformation Patients
    Kim, Helen
    Nelson, Jeffrey
    Salman, Rustam Al-Shahi
    Flemming, Kelly
    Hess, Christopher
    Hetts, Steven W.
    Koroknay-Pal, Paivi
    Laakso, Aki
    Lanzino, Giuseppe S.
    Lawton, Michael
    McCulloch, Charles
    Moayeri, Nicole
    Mohr, Jay P.
    Morgan, Michael
    Stefani, Marco
    Zaroff, Jonathan
    Zhao, Yuanli
    STROKE, 2023, 54
  • [30] Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation
    Choi, JH
    Mast, H
    Sciacca, RR
    Hartmann, A
    Khaw, AV
    Mohr, JP
    Sacco, RL
    Stapf, C
    STROKE, 2006, 37 (05) : 1243 - 1247